Publications 2025

Almåsbak H, Sioud M, Rasmussen AM (2025)
Engineering mRNA CAR-T Cells for Cancer Immunotherapy
2965, 285-321
DOI 10.1007/978-1-0716-4742-4_14, PubMed 40877511

Hønnåshagen TK, Skoge LJ, Sæbøe-Larssen S, Håkenstad H, Kvalheim G, Sioud M (2025)
Production of mRNA-Loaded Dendritic Cell Cancer Vaccines
2965, 245-258
DOI 10.1007/978-1-0716-4742-4_11, PubMed 40877508

Mobergslien A, Sioud M (2025)
Chemical Strategies to Enhance Antisense Strand Selection and Minimize Off-Target Effect-Mediated by siRNAs
2965, 479-488
DOI 10.1007/978-1-0716-4742-4_25, PubMed 40877522

Sioud M (2025)
RNA Therapeutics: Bridging Discovery and Clinical Implementation
2965, 1-37
DOI 10.1007/978-1-0716-4742-4_1, PubMed 40877498

Sioud M (2025)
Molecular Mechanisms of Innate Immune Sensing of Exogenous RNAs
2965, 39-56
DOI 10.1007/978-1-0716-4742-4_2, PubMed 40877499

Sioud M (2025)
Effects of Nucleoside Modifications on mRNA Translation: Choosing the Right Modifications
2965, 127-149
DOI 10.1007/978-1-0716-4742-4_4, PubMed 40877501

Sioud M (2025)
Assessing the Immunogenicity of Synthetic RNA Using Blood Cells
2965, 179-187
DOI 10.1007/978-1-0716-4742-4_6, PubMed 40877503

Sæbøe-Larssen S, Sioud M (2025)
Large-Scale Production of Unmodified mRNA for Reprogramming Human Dendritic Cells and T Cells
2965, 235-244
DOI 10.1007/978-1-0716-4742-4_10, PubMed 40877507

Sæbøe-Larssen S, Sioud M (2025)
Enhancing Cancer Vaccine Efficacy: siRNA-Based Modulation of Immune Suppressive Factors in Dendritic Cells
2965, 259-273
DOI 10.1007/978-1-0716-4742-4_12, PubMed 40877509

Publications 2024

Sioud M, Juzeniene A, Sæbøe-Larssen S (2024)
Exploring the Impact of mRNA Modifications on Translation Efficiency and Immune Tolerance to Self-Antigens
12 (6)
DOI 10.3390/vaccines12060624, PubMed 38932353

Publications 2023

Sioud M (2023)
How the initial discovery of modified RNA enabled evasion of innate immune responses and facilitated the development of RNA therapeutics
98 (1), e13282
DOI 10.1111/sji.13282, PubMed 37132451

Sioud M, Olberg A (2023)
Antibody Surface Profiling Identifies Glycoforms in Multiple Myeloma as Targets for Immunotherapy: From Antibody Derivatives to Mimetic Peptides for Killing Tumor Cells
15 (7)
DOI 10.3390/cancers15071934, PubMed 37046595

Sioud M, Zhang Q (2023)
Precision Killing of M2 Macrophages with Phage-Displayed Peptide-Photosensitizer Conjugates
15 (7)
DOI 10.3390/cancers15072009, PubMed 37046671

Zhang Q, Sioud M (2023)
Tumor-Associated Macrophage Subsets: Shaping Polarization and Targeting
24 (8)
DOI 10.3390/ijms24087493, PubMed 37108657

Publications 2022

Zhang Q, Olberg A, Sioud M (2022)
Structural Requirements for the Binding of a Peptide to Prohibitins on the Cell Surface of Monocytes/Macrophages
23 (8)
DOI 10.3390/ijms23084282, PubMed 35457098

Publications 2021

Sioud M (2021)
RNA Interference: Story and Mechanisms
2282, 1-15
DOI 10.1007/978-1-0716-1298-9_1, PubMed 33928566

Sioud M (2021)
Reducing the immunosuppressive tumor microenvironment enhances photoimmunotherapy efficacy
67, 103351
DOI 10.1016/j.ebiom.2021.103351, PubMed 33965875

Sioud M, Juzenas P, Zhang Q, Kleinauskas A, Peng Q (2021)
Evaluation of In Vitro Phototoxicity of a Minibody-IR700 Conjugate Using Cell Monolayer and Multicellular Tumor Spheroid Models
13 (13)
DOI 10.3390/cancers13133356, PubMed 34283089

Sioud M, Juzenas P, Zhang Q, Kleinauskas A, Peng Q (2021)
Correction: Sioud et al. Evaluation of In Vitro Phototoxicity of a Minibody-IR700 Conjugate Using Monolayer and Multicellular Tumor Spheroid Models. Cancers 2021, 13, 3356
13 (21)
DOI 10.3390/cancers13215513, PubMed 34771754

Publications 2020

Darvekar S, Juzenas P, Oksvold M, Kleinauskas A, Holien T, Christensen E, Stokke T, Sioud M, Peng Q (2020)
Selective Killing of Activated T Cells by 5-Aminolevulinic Acid Mediated Photodynamic Effect: Potential Improvement of Extracorporeal Photopheresis
12 (2)
DOI 10.3390/cancers12020377, PubMed 32041351

Iversen PO, Sioud M (2020)
Harnessing the Antiviral-Type Responses Induced by Immunostimulatory siRNAs for Cancer Immunotherapy
2115, 281-287
DOI 10.1007/978-1-0716-0290-4_16, PubMed 32006407

Mobergslien A, Sioud M (2020)
Exploring 5'-Biotinylation of the Sense Strand to Improve siRNA Specificity and Potency
2115, 163-170
DOI 10.1007/978-1-0716-0290-4_9, PubMed 32006400

Sioud M (2020)
RNA and CRISPR Interferences: Past, Present, and Future Perspectives
2115, 1-22
DOI 10.1007/978-1-0716-0290-4_1, PubMed 32006392

Sioud M (2020)
Optimized siRNA Delivery into Primary Immune Cells Using Electroporation
2115, 119-131
DOI 10.1007/978-1-0716-0290-4_7, PubMed 32006398

Sioud M (2020)
Unleashing the Therapeutic Potential of Dendritic and T Cell Therapies Using RNA Interference
2115, 259-280
DOI 10.1007/978-1-0716-0290-4_15, PubMed 32006406

Sioud M (2020)
Microbial sensing by haematopoietic stem and progenitor cells: Vigilance against infections and immune education of myeloid cells
92 (5), e12957
DOI 10.1111/sji.12957, PubMed 32767789

Sæbøe-Larssen S, Sioud M (2020)
Improving Dendritic Cell Cancer Vaccine Potency Using RNA Interference
2115, 249-258
DOI 10.1007/978-1-0716-0290-4_14, PubMed 32006405

Wälchli S, Sioud M (2020)
Next Generation of Adoptive T Cell Therapy Using CRISPR/Cas9 Technology: Universal or Boosted?
2115, 407-417
DOI 10.1007/978-1-0716-0290-4_22, PubMed 32006413

Publications 2019

Sioud M (2019)
Releasing the Immune System Brakes Using siRNAs Enhances Cancer Immunotherapy
11 (2)
DOI 10.3390/cancers11020176, PubMed 30717461

Sioud M (2019)
Phage Display Libraries: From Binders to Targeted Drug Delivery and Human Therapeutics
61 (4), 286-303
DOI 10.1007/s12033-019-00156-8, PubMed 30729435

Sioud M, Pettersen S, Ailte I, Fløisand Y (2019)
Targeted Killing of Monocytes/Macrophages and Myeloid Leukemia Cells with Pro-Apoptotic Peptides
11 (8)
DOI 10.3390/cancers11081088, PubMed 31370273

Publications 2018

Peng W, de Bruijn HS, Farrell E, Sioud M, Mashayekhi V, Oliveira S, van Dam GM, Roodenburg JLN, Witjes MJH, Robinson DJ (2018)
Epidermal growth factor receptor (EGFR) density may not be the only determinant for the efficacy of EGFR-targeted photoimmunotherapy in human head and neck cancer cell lines
50 (5), 513-522
DOI 10.1002/lsm.22930, PubMed 29777587

Sioud M (2018)
T-cell cross-reactivity may explain the large variation in how cancer patients respond to checkpoint inhibitors
87 (3)
DOI 10.1111/sji.12643, PubMed 29381830

Sioud M, Westby P, Vasovic V, Fløisand Y, Peng Q (2018)
Development of a new high-affinity human antibody with antitumor activity against solid and blood malignancies
32 (9), 5063-5077
DOI 10.1096/fj.201701544R, PubMed 29913558

Publications 2016

Mobergslien A, Peng Q, Vasovic V, Sioud M (2016)
Cancer cell-binding peptide fused Fc domain activates immune effector cells and blocks tumor growth
7 (46), 75940-75953
DOI 10.18632/oncotarget.12445, PubMed 27713158

Sioud M, Nyakas M, Sæbøe-Larssen S, Mobergslien A, Aamdal S, Kvalheim G (2016)
Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO-Silenced Dendritic Cell Vaccine
2016, 9639585
DOI 10.1155/2016/9639585, PubMed 27504122

Zins K, Schäfer R, Paulus P, Dobler S, Fakhari N, Sioud M, Aharinejad S, Abraham D (2016)
Frizzled2 signaling regulates growth of high-risk neuroblastomas by interfering with β-catenin-dependent and β-catenin-independent signaling pathways
7 (29), 46187-46202
DOI 10.18632/oncotarget.10070, PubMed 27323822

Publications 2015

Iversen PO, Sioud M (2015)
Engineering therapeutic cancer vaccines that activate antitumor immunity
1218, 263-8
DOI 10.1007/978-1-4939-1538-5_15, PubMed 25319656

Mobergslien A, Sioud M (2015)
A facile method for interfering with off-target silencing mediated by the sense strand
1218, 293-300
DOI 10.1007/978-1-4939-1538-5_18, PubMed 25319659

Mobergslien A, Vasovic V, Mathiesen G, Fredriksen L, Westby P, Eijsink VG, Peng Q, Sioud M (2015)
Recombinant Lactobacillus plantarum induces immune responses to cancer testis antigen NY-ESO-1 and maturation of dendritic cells
11 (11), 2664-73
DOI 10.1080/21645515.2015.1056952, PubMed 26185907

Sioud M (2015)
RNA interference: mechanisms, technical challenges, and therapeutic opportunities
1218, 1-15
DOI 10.1007/978-1-4939-1538-5_1, PubMed 25319642

Sioud M (2015)
Strategies for siRNA navigation to desired cells
1218, 201-16
DOI 10.1007/978-1-4939-1538-5_12, PubMed 25319653

Sioud M (2015)
Overcoming the challenges of siRNA activation of innate immunity: design better therapeutic siRNAs
1218, 301-19
DOI 10.1007/978-1-4939-1538-5_19, PubMed 25319660

Sioud M (2015)
Modified 2'-ribose small RNAs function as Toll-like receptor-7/8 antagonists
1218, 483-9
DOI 10.1007/978-1-4939-1538-5_28, PubMed 25319669

Sioud M, Mobergslien A, Sæbøe-Larssen S (2015)
Immunosuppressive factor blockade in dendritic cells via siRNAs results in objective clinical responses
1218, 269-76
DOI 10.1007/978-1-4939-1538-5_16, PubMed 25319657

Sioud M, Westby P, Olsen JK, Mobergslien A (2015)
Generation of new peptide-Fc fusion proteins that mediate antibody-dependent cellular cytotoxicity against different types of cancer cells
2, 15043
DOI 10.1038/mtm.2015.43, PubMed 26605373

Publications 2014

Sioud M (2014)
Engineering better immunotherapies via RNA interference
10 (11), 3165-74
DOI 10.4161/hv.29754, PubMed 25483669

Publications 2013

Mobergslien A, Sioud M (2013)
Exosome-derived miRNAs and cellular miRNAs activate innate immunity
6 (1), 105-10
DOI 10.1159/000351460, PubMed 23774807

Shahzidi S, Brech A, Sioud M, Li X, Suo Z, Nesland JM, Peng Q (2013)
Lamin A/C cleavage by caspase-6 activation is crucial for apoptotic induction by photodynamic therapy with hexaminolevulinate in human B-cell lymphoma cells
339 (1), 25-32
DOI 10.1016/j.canlet.2013.07.026, PubMed 23916608

Sioud M, Saebøe-Larssen S, Hetland TE, Kaern J, Mobergslien A, Kvalheim G (2013)
Silencing of indoleamine 2,3-dioxygenase enhances dendritic cell immunogenicity and antitumour immunity in cancer patients
43 (1), 280-8
DOI 10.3892/ijo.2013.1922, PubMed 23620105

Sioud M, Skorstad G, Mobergslien A, Sæbøe-Larssen S (2013)
A novel peptide carrier for efficient targeting of antigens and nucleic acids to dendritic cells
27 (8), 3272-83
DOI 10.1096/fj.12-224758, PubMed 23671272

Zins K, Thomas A, Lucas T, Sioud M, Aharinejad S, Abraham D (2013)
Inhibition of Stromal PlGF Suppresses the Growth of Prostate Cancer Xenografts
Int. J. Mol. Sci., 14 (9), 17958-17971
DOI 10.3390/ijms140917958

Publications 2012

Sioud M, Mobergslien A (2012)
Efficient siRNA targeted delivery into cancer cells by gastrin-releasing peptides
23 (5), 1040-9
DOI 10.1021/bc300050j, PubMed 22443209

Sioud M, Mobergslien A (2012)
Selective killing of cancer cells by peptide-targeted delivery of an anti-microbial peptide
84 (9), 1123-32
DOI 10.1016/j.bcp.2012.08.002, PubMed 22922046

Publications 2011

Mobergslien A, Sioud M (2011)
Galectin-1 and -3 gene silencing in immature and mature dendritic cells enhances T cell activation and interferon-γ production
91 (3), 461-7
DOI 10.1189/jlb.0711361, PubMed 22167721

Sioud M (2011)
New insights into mesenchymal stromal cell-mediated T-cell suppression through galectins
73 (2), 79-84
DOI 10.1111/j.1365-3083.2010.02491.x, PubMed 21198747

Publications 2010

Abraham D, Zins K, Sioud M, Lucas T, Schafer R, Stanley ER, Aharinejad S (2010)
Stromal cell-derived CSF-1 blockade prolongs xenograft survival of CSF-1-negative neuroblastoma
Int. J. Cancer, 126 (6), 1339-1352
DOI 10.1002/ijc.24859

Cekaite L, Clancy T, Sioud M (2010)
Increased miR-21 expression during human monocyte differentiation into DCs
2 (3), 818-28
DOI 10.2741/e143, PubMed 20515755

Fløisand Y, Sioud M (2010)
Recent advances in hematopoietic stem cell transplantation and perspectives of RNAi applications
629, 507-23
DOI 10.1007/978-1-60761-657-3_30, PubMed 20387168

Fredriksen L, Mathiesen G, Sioud M, Eijsink VGH (2010)
Cell Wall Anchoring of the 37-Kilodalton Oncofetal Antigen by Lactobacillus plantarum for Mucosal Cancer Vaccine Delivery
Appl. Environ. Microbiol., 76 (21), 7359-7362
DOI 10.1128/AEM.01031-10

Iversen PO, Sørensen DR, Sioud M (2010)
A combined immunostimulatory and immunoinhibitory short interference RNA reduces hypercoagulability in a rat model of acute promyelocytic leukaemia
104 (2), 350-4
DOI 10.1160/TH09-12-0816, PubMed 20539915

Mobergslien A, Sioud M (2010)
Optimized protocols for siRNA delivery into monocytes and dendritic cells
629, 71-85
DOI 10.1007/978-1-60761-657-3_5, PubMed 20387143

Sioud M (2010)
Advances in RNA sensing by the immune system: separation of siRNA unwanted effects from RNA interference
629, 33-52
DOI 10.1007/978-1-60761-657-3_3, PubMed 20387141

Sioud M (2010)
What are the key targeted delivery technologies of siRNA now?
629, 93-107
DOI 10.1007/978-1-60761-657-3_7, PubMed 20387145

Sioud M (2010)
Development of TLR7/8 small RNA antagonists
629, 387-94
DOI 10.1007/978-1-60761-657-3_25, PubMed 20387163

Sioud M (2010)
Modulation of dendritic cell maturation and function by siRNA-bearing 5'-triphosphate
629, 395-404
DOI 10.1007/978-1-60761-657-3_26, PubMed 20387164

Sioud M (2010)
Overcoming self-tolerance to tumour cells
629, 495-505
DOI 10.1007/978-1-60761-657-3_29, PubMed 20387167

Sioud M (2010)
Recent advances in small interfering RNA sensing by the immune system
New Biotech., 27 (3), 236-242
DOI 10.1016/j.nbt.2010.02.015

Sioud M (2010)
RNA therapeutics: function, design, and delivery
Humana Press, New York, XVI, 526 s.
BIBSYS 111098939, ISBN 978-1-60761-656-6

Sioud M, Cekaite L (2010)
Profiling of miRNA expression and prediction of target genes
629, 257-71
DOI 10.1007/978-1-60761-657-3_16, PubMed 20387154

Sioud M, Mobergslien A, Boudabous A, Fløisand Y (2010)
Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferation
71 (4), 267-74
DOI 10.1111/j.1365-3083.2010.02378.x, PubMed 20384870

Sioud M, Mobergslien A, Boudabous A, Fløisand Y (2010)
Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins
38 (2), 385-90
DOI 10.3892/ijo.2010.869, PubMed 21165555

Sørensen DR, Sioud M (2010)
Systemic delivery of synthetic siRNAs
629, 87-91
DOI 10.1007/978-1-60761-657-3_6, PubMed 20387144

Publications 2009

Cekaite L, Hovig E, Sioud M (2009)
Monitoring B cell response to immunoselected phage-displayed peptides by microarrays
524, 273-85
DOI 10.1007/978-1-59745-450-6_20, PubMed 19377952

Flatekval GF, Sioud M (2009)
Modulation of dendritic cell maturation and function with mono- and bifunctional small interfering RNAs targeting indoleamine 2,3-dioxygenase
128 (1 Suppl), e837-48
DOI 10.1111/j.1365-2567.2009.03093.x, PubMed 19740345

Hauge H, Fjelland KE, Sioud M, Aasheim HC (2009)
Evidence for the involvement of FAM110C protein in cell spreading and migration
21 (12), 1866-73
DOI 10.1016/j.cellsig.2009.08.001, PubMed 19698782

Iversen PO, Semaeva E, Sorensen DR, Wiig H, Sioud M (2009)
Dendritic Cells Loaded with Tumor Antigens and a Dual Immunostimulatory and Anti-Interleukin 10-Specific Small Interference RNA Prime T Lymphocytes against Leukemic Cells
2 (4), 242-6
DOI 10.1593/tlo.09154, PubMed 19956385

Sioud M (2009)
Does our Current Understanding of Immune Tolerance, Autoimmunity, and Immunosuppressive Mechanisms Facilitate the Design of Efficient Cancer Vaccines?
Scand. J. Immunol., 70 (6), 516-525
DOI 10.1111/j.1365-3083.2009.02326.x

Sioud M (2009)
siRNA and miRNA gene silencing: from bench to bedside
Humana Press, New York, XIV, 472 s.
BIBSYS 082628173, ISBN 9781603275460

Sioud M, Boudabous A, Cekaite L (2009)
Transcriptional responses of Bacillus subtillis and thuringiensis to antibiotics and anti-tumour drugs
Int. J. Mol. Med., 23 (1), 33-39
DOI 10.3892/ijmm_00000098

Sioud M, Fløisand Y (2009)
NOD2/CARD15 on bone marrow CD34+ hematopoietic cells mediates induction of cytokines and cell differentiation
85 (6), 939-46
DOI 10.1189/jlb.1008650, PubMed 19244164

Publications 2008

Abraham D, Zins K, Sioud M, Lucas T, Aharinejad S (2008)
Host CD147 blockade by small interfering RNAs suppresses growth of human colon cancer xenografts
13, 5571-9
DOI 10.2741/3100, PubMed 18508606

Abraham D, Zins K, Sioud M, Lucas T, Aharinejad S (2008)
Host CD147 blockade by small interfering RNAs suppresses growth of human colon cancer xenografts
Front. Biosci., 13, 5571-5579

Chekenya M, Krakstad C, Svendsen A, Netland IA, Staalesen V, Tysnes BB, Selheim F, Wang J, Sakariassen PØ, Sandal T, Lønning PE, Flatmark T, Enger PØ, Bjerkvig R, Sioud M, Stallcup WB (2008)
The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling
27 (39), 5182-94
DOI 10.1038/onc.2008.157, PubMed 18469852

Shadidi M, Sorensen D, Dybwad A, Furset G, Sioud M (2008)
Mucosal vaccination with phage-displayed tumour antigens identified through proteomics-based strategy inhibits the growth and metastasis of 4T1 breast adenocarcinoma
Int. J. Oncol., 32 (1), 241-247

Shadidi M, Sørensen D, Dybwad A, Furset G, Sioud M (2008)
Mucosal vaccination with phage-displayed tumour antigens identified through proteomics-based strategy inhibits the growth and metastasis of 4T1 breast adenocarcinoma
32 (1), 241-7
PubMed 18097564

Sioud M (2008)
Does the understanding of immune activation by RNA predict the design of safe siRNAs?
13, 4379-92
DOI 10.2741/3011, PubMed 18508517

Sioud M, Cekaite L (2008)
Expression profiling of microRNAs in cancer cells: technical considerations
439, 179-90
DOI 10.1007/978-1-59745-188-8_12, PubMed 18370103

Walchli S, Sioud M (2008)
Vector-based delivery of siRNAs: in vitro and in vivo challenges
13, 3488-93
DOI 10.2741/2943, PubMed 18508450

Walchli S, Sioud M (2008)
Vector-based delivery of siRNAs: In vitro and in vivo challenges
Front. Biosci., 13, 3488-3493

Publications 2007

Aharinejad S, Sioud M, Lucas T, Abraham D (2007)
Target validation using RNA interference in solid tumors
361, 227-38
DOI 10.1385/1-59745-208-4:227, PubMed 17172715

Cekaite L, Hovig E, Sioud M (2007)
Protein arrays: a versatile toolbox for target identification and monitoring of patient immune responses
360, 335-48
DOI 10.1385/1-59745-165-7:335, PubMed 17172738

Furset G, Fløisand Y, Sioud M (2007)
Impaired expression of indoleamine 2, 3-dioxygenase in monocyte-derived dendritic cells in response to Toll-like receptor-7/8 ligands
123 (2), 263-71
DOI 10.1111/j.1365-2567.2007.02695.x, PubMed 17725606

Røsok Ø, Sioud M (2007)
Discovery of differentially expressed genes: technical considerations
360, 115-29
DOI 10.1385/1-59745-165-7:115, PubMed 17172727

Sioud M (2007)
Main approaches to target discovery and validation
360, 1-12
DOI 10.1385/1-59745-165-7:1, PubMed 17172722

Sioud M (2007)
An overview of the immune system and technical advances in tumor antigen discovery and validation
360, 277-318
DOI 10.1385/1-59745-165-7:277, PubMed 17172735

Sioud M (2007)
RNA interference and innate immunity
59 (2-3), 153-63
DOI 10.1016/j.addr.2007.03.006, PubMed 17459518

Sioud M (2007)
Target discovery and validation: reviews and protocols
Humana Press, Totowa, N.J., 2 v.
BIBSYS 070956626

Sioud M, Fløisand Y (2007)
TLR agonists induce the differentiation of human bone marrow CD34+ progenitors into CD11c+ CD80/86+ DC capable of inducing a Th1-type response
37 (10), 2834-46
DOI 10.1002/eji.200737112, PubMed 17853407

Sioud M, Furset G, Cekaite L (2007)
Suppression of immunostimulatory siRNA-driven innate immune activation by 2'-modified RNAs
361 (1), 122-6
DOI 10.1016/j.bbrc.2007.06.177, PubMed 17658482

Sioud M, Leirdal M (2007)
Druggable signaling proteins
361, 1-24
DOI 10.1385/1-59745-208-4:1, PubMed 17172705

Sioud M, Melien O (2007)
Treatment options and individualized medicine
361, 327-40
DOI 10.1385/1-59745-208-4:327, PubMed 17172721

Zins K, Abraham D, Sioud M, Aharinejad S (2007)
Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway
67 (3), 1038-45
DOI 10.1158/0008-5472.CAN-06-2295, PubMed 17283136

Publications 2006

Angell-Petersen E, Spetalen S, Madsen SJ, Sun CH, Peng Q, Carper SW, Sioud M, Hirschberg H (2006)
Influence of light fluence rate on the effects of photodynamic therapy in an orthotopic rat glioma model
104 (1), 109-17
DOI 10.3171/jns.2006.104.1.109, PubMed 16509154

Cekaite L, Furset G, Hovig E, Sioud M (2006)
Gene expression analysis in blood cells in response to unmodified and 2'-modified siRNAs reveals TLR-dependent and independent effects
365 (1), 90-108
DOI 10.1016/j.jmb.2006.09.034, PubMed 17054988

Furset G, Sioud M (2006)
Design of bifunctional siRNAs: combining immunostimulation and gene-silencing in one single siRNA molecule
352 (3), 642-9
DOI 10.1016/j.bbrc.2006.11.059, PubMed 17150189

Huynh T, Wälchli S, Sioud M (2006)
Transcriptional targeting of small interfering RNAs into cancer cells
350 (4), 854-9
DOI 10.1016/j.bbrc.2006.09.127, PubMed 17034763

Sioud M (2006)
Innate sensing of self and non-self RNAs by Toll-like receptors
12 (4), 167-76
DOI 10.1016/j.molmed.2006.02.004, PubMed 16530484

Sioud M (2006)
Ribozymes and siRnas: from structure to preclinical applications
(173), 223-42
DOI 10.1007/3-540-27262-3_11, PubMed 16594618

Sioud M (2006)
Single-stranded small interfering RNA are more immunostimulatory than their double-stranded counterparts: a central role for 2'-hydroxyl uridines in immune responses
36 (5), 1222-30
DOI 10.1002/eji.200535708, PubMed 16609928

Sioud M (2006)
RNA interference below the immune radar
24 (5), 521-2
DOI 10.1038/nbt0506-521, PubMed 16680132

Sioud M (2006)
RNAi therapy: antibodies guide the way
13 (3), 194-5
DOI 10.1038/sj.gt.3302634, PubMed 17243203

Sioud M, Fløisand Y, Forfang L, Lund-Johansen F (2006)
Signaling through toll-like receptor 7/8 induces the differentiation of human bone marrow CD34+ progenitor cells along the myeloid lineage
364 (5), 945-54
DOI 10.1016/j.jmb.2006.09.054, PubMed 17049554

Sioud M, Furset G (2006)
Molecular basis for the immunostimulatory potency of small interfering RNAs
2006 (4), 23429
DOI 10.1155/JBB/2006/23429, PubMed 17057361

Sioud M, Haoudi A (2006)
RNA interference
2006 (4), 89018
DOI 10.1155/JBB/2006/89018, PubMed 17057373

Publications 2005

Patzke S, Hauge H, Sioud M, Finne EF, Sivertsen EA, Delabie J, Stokke T, Aasheim HC (2005)
Identification of a novel centrosome/microtubule-associated coiled-coil protein involved in cell-cycle progression and spindle organization
24 (7), 1159-73
DOI 10.1038/sj.onc.1208267, PubMed 15580290

Rosok O, Sioud M (2005)
Systematic search for natural antisense transcripts in eukaryotes - (Review)
Int. J. Mol. Med., 15 (2), 197-203

Røsok O, Sioud M (2005)
Systematic search for natural antisense transcripts in eukaryotes (review)
15 (2), 197-203
PubMed 15647831

Sioud M (2005)
Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization
348 (5), 1079-90
DOI 10.1016/j.jmb.2005.03.013, PubMed 15854645

Sioud M (2005)
siRNA delivery in vivo
309, 237-49
DOI 10.1385/1-59259-935-4:237, PubMed 15990404

Sioud M (2005)
On the delivery of small interfering RNAs into mammalian cells
2 (4), 639-51
DOI 10.1517/17425247.2.4.639, PubMed 16296791

Sioud M, Iversen PO (2005)
Ribozymes, DNAzymes and small interfering RNAs as therapeutics
6 (6), 647-53
DOI 10.2174/1389450054863653, PubMed 16178798

Sioud M, Røsok Ø (2005)
High-throughput analysis of microRNA gene expression using sensitive probes
309, 311-20
DOI 10.1385/1-59259-935-4:311, PubMed 15990410

Sioud M, Wälchli S (2005)
Strategies for the design of random siRNA libraries and the selection of anti-GFP siRNAs
309, 83-91
DOI 10.1385/1-59259-935-4:083, PubMed 15990399

Publications 2004

Aharinejad S, Paulus P, Sioud M, Hofmann M, Zins K, Schäfer R, Stanley ER, Abraham D (2004)
Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice
64 (15), 5378-84
DOI 10.1158/0008-5472.CAN-04-0961, PubMed 15289345

Cekaite L, Haug O, Myklebost O, Aldrin M, Østenstad B, Holden M, Frigessi A, Hovig E, Sioud M (2004)
Analysis of the humoral immune response to immunoselected phage-displayed peptides by a microarray-based method
4 (9), 2572-82
DOI 10.1002/pmic.200300768, PubMed 15352232

Hirschberg H, Madsen S, Angell-Petersen E, Peng Q, Sioud M, Sun CH, Sorensen DR (2004)
Repetitive 5-aminolevulinic acid mediated photodynamic therapy of rat glioma
P SOC PHOTO-OPT INS, 5312, 405-414
DOI 10.1117/12.527395

Iversen PO, Sioud M (2004)
Inhibition of gene expression by nucleic acid enzymes in rodent models of human disease
252, 451-6
DOI 10.1385/1-59259-746-7:451, PubMed 15017070

Leirdal M, Shadidy M, Rosok O, Sioud M (2004)
Identification of genes differentially expressed in breast cancer cell line SKBR3: Potential identification of new prognostic biomarkers
Int. J. Mol. Med., 14 (2), 217-222

Leirdal M, Shadidy M, Røsok Ø, Sioud M (2004)
Identification of genes differentially expressed in breast cancer cell line SKBR3: potential identification of new prognostic biomarkers
14 (2), 217-22
PubMed 15254768

Leirdal M, Sioud M (2004)
Gene-array analysis of glioma cells after treatment with an anti-PKCalpha siRNA: a general protocol
252, 493-500
DOI 10.1385/1-59259-746-7:493, PubMed 15017074

Shadidi M, Sioud M (2004)
Selection of peptides for specific delivery of oligonucleotides into cancer cells
252, 569-80
DOI 10.1385/1-59259-746-7:569, PubMed 15017081

Sioud M (2004)
Therapeutic siRNAs
25 (1), 22-8
DOI 10.1016/j.tips.2003.11.006, PubMed 14723975

Sioud M (2004)
Ribozyme- and siRNA-mediated mRNA degradation: a general introduction
252, 1-8
DOI 10.1385/1-59259-746-7:001, PubMed 15017038

Sioud M (2004)
Therapeutic potential of small interfering RNAs
Drug Future, 29 (7), 741-750
DOI 10.1358/dof.2004.029.07.854171

Sioud M (2004)
Ribozymes and siRNA protocols
Humana Press, Totowa, N.J. (2nd ed.), p.
BIBSYS 04060053x, ISBN 1-58829-226-6

Sioud M, Leirdal M (2004)
Potential design rules and enzymatic synthesis of siRNAs
252, 457-69
DOI 10.1385/1-59259-746-7:457, PubMed 15017071

Sioud M, Røsok O (2004)
Profiling microRNA expression using sensitive cDNA probes and filter arrays
37 (4), 574-6, 578-80
DOI 10.2144/04374ST01, PubMed 15517969

Sioud M, Sørensen DR (2004)
Systemic delivery of synthetic siRNAs
252, 515-22
DOI 10.1385/1-59259-746-7:515, PubMed 15017077

Publications 2003

Dybwad A, Lambin P, Sioud M, Zouali M (2003)
Probing the specificity of human myeloma proteins with a random peptide phage library
57 (6), 583-90
DOI 10.1046/j.1365-3083.2003.01254.x, PubMed 12791097

Røsok Ø, Sioud M (2003)
Systematic identification of sense-antisense transcripts in mammalian cells
22 (1), 104-8
DOI 10.1038/nbt925, PubMed 14704709

Shadidi M, Sioud M (2003)
Selective targeting of cancer cells using synthetic peptides
6 (6), 363-71
DOI 10.1016/j.drup.2003.11.002, PubMed 14744500

Sioud M, Sørensen D (2003)
Generation of an effective anti-tumor immunity after immunization with xenogeneic antigens
33 (1), 38-45
DOI 10.1002/immu.200390005, PubMed 12594830

Sioud M, Sørensen DR (2003)
Cationic liposome-mediated delivery of siRNAs in adult mice
312 (4), 1220-5
DOI 10.1016/j.bbrc.2003.11.057, PubMed 14652004

Sørensen DR, Leirdal M, Sioud M (2003)
Gene silencing by systemic delivery of synthetic siRNAs in adult mice
327 (4), 761-6
DOI 10.1016/s0022-2836(03)00181-5, PubMed 12654261

Publications 2002

Iversen PO, Emanuel PD, Sioud M (2002)
Targeting Raf-1 gene expression by a DNA enzyme inhibits juvenile myelomonocytic leukemia cell growth
99 (11), 4147-53
DOI 10.1182/blood.v99.11.4147, PubMed 12010819

Leirdal M, Sioud M (2002)
[Tyrosine kinase receptor-ras-ERK signal transduction pathway as therapeutic tarfet in cancer]
122 (2), 178-82
PubMed 11873574

Leirdal M, Sioud M (2002)
Gene silencing in mammalian cells by preformed small RNA duplexes
295 (3), 744-8
DOI 10.1016/s0006-291x(02)00736-2, PubMed 12099702

Shadidi M, Sioud M (2002)
Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells
17 (2), 256-8
DOI 10.1096/fj.02-0280fje, PubMed 12490548

Sioud M (2002)
How does autoimmunity cause tumor regression? A potential mechanism involving cross-reaction through epitope mimicry
8 (3), 115-9
PubMed 12142543

Sioud M (2002)
How does autoimmunity cause tumor regression? A potential mechanism involving cross-reaction through epitope mimicry
Mol. Med., 8 (3), 115-119
DOI 10.1007/BF03402004

Sorensen DR, Leirdal M, Iversen PO, Sioud M (2002)
Combination of endostatin and a protein kinase Calpha DNA enzyme improves the survival of rats with malignant glioma
4 (6), 474-9
DOI 10.1038/sj.neo.7900271, PubMed 12407440

Publications 2001

Hansen MH, Ostenstad B, Sioud M (2001)
Antigen-specific IgG antibodies in stage IV long-time survival breast cancer patients
7 (4), 230-9
PubMed 11471567

Hansen MH, Ostenstad B, Sioud M (2001)
Identification of immunogenic antigens using a phage-displayed cDNA library from an invasive ductal breast carcinoma tumour
19 (6), 1303-9
DOI 10.3892/ijo.19.6.1303, PubMed 11713604

Hansen MH, Ostenstad B, Sioud M (2001)
Antigen-specific IgG antibodies in stage IV long-time survival breast cancer patients
Mol. Med., 7 (4), 230-239
DOI 10.1007/BF03401842

Hansen MH, Ostenstad B, Sioud M (2001)
Identification of immunogenic antigens using a phage-displayed cDNA library from an invasive ductal breast carcinoma tumour
Int. J. Oncol., 19 (6), 1303-1309

Iversen PO, Nicolaysen G, Sioud M (2001)
DNA enzyme targeting TNF-alpha mRNA improves hemodynamic performance in rats with postinfarction heart failure
281 (5), H2211-7
DOI 10.1152/ajpheart.2001.281.5.H2211, PubMed 11668085

Melien O, Christoffersen T, Sioud M (2001)
Evidence for the involvement of Gi2 in activation of extracellular signal-regulated kinases in hepatocytes
2, 13
DOI 10.1186/1471-2121-2-13, PubMed 11495629

Shadidi M, Sioud M (2001)
An anti-leukemic single chain Fv antibody selected from a synthetic human phage antibody library
280 (2), 548-52
DOI 10.1006/bbrc.2000.4158, PubMed 11162553

Sioud M (2001)
Nucleic acid enzymes as a novel generation of anti-gene agents
1 (5), 575-88
DOI 10.2174/1566524013363366, PubMed 11899232

Sioud M, Hansen MH (2001)
Profiling the immune response in patients with breast cancer by phage-displayed cDNA libraries
31 (3), 716-25
DOI 10.1002/1521-4141(200103)31:3<716::aid-immu716>3.0.co;2-9, PubMed 11241275

Publications 2000

Hansen MH, Dybwad A, Forre O, Sioud M (2000)
Probing antinuclear antibody specificities by peptide phage display libraries
Clin. Exp. Rheumatol., 18 (4), 465-472

Hansen MH, Dybwad A, Førre O, Sioud M (2000)
Probing antinuclear antibody specificities by peptide phage display libraries
18 (4), 465-72
PubMed 10949721

Josefsen D, Myklebust JH, Lømo J, Sioud M, Blomhoff HK, Smeland EB (2000)
Differential expression of bcl-2 homologs in human CD34(+) hematopoietic progenitor cells induced to differentiate into erythroid or granulocytic cells
18 (4), 261-72
DOI 10.1634/stemcells.18-4-261, PubMed 10924092

Myklebust JH, Smeland EB, Josefsen D, Sioud M (2000)
Protein kinase C-alpha isoform is involved in erythropoietin-induced erythroid differentiation of CD34(+) progenitor cells from human bone marrow
Blood, 95 (2), 510-518
DOI 10.1182/blood.V95.2.510

Sioud M, Hansen M, Dybwad A (2000)
Profiling the immune responses in patient sera with peptide and cDNA display libraries (Review)
Int. J. Mol. Med., 6 (2), 123-128

Sioud M, Leirdal M (2000)
Design of nuclease resistant protein kinase C alpha DNA enzymes with potential therapeutic application
J. Mol. Biol., 296 (3), 937-947
DOI 10.1006/jmbi.2000.3491

Sioud M, Leirdal M (2000)
Therapeutic RNA and DNA enzymes
Biochem. Pharmacol., 60 (8), 1023-1026
DOI 10.1016/S0006-2952(00)00395-6

Publications 1999

Leirdal M, Sioud M (1999)
Ribozyme inhibition of the protein kinase C alpha triggers apoptosis in glioma cells
Br. J. Cancer, 80 (10), 1558-1564
DOI 10.1038/sj.bjc.6990560

Sioud M (1999)
Application of preformed hammerhead ribozymes in the gene therapy of cancer (Review)
Int. J. Mol. Med., 3 (4), 381-384

Sioud M, Leirdal M (1999)
Substitution of the 2 '-hydroxyl group at position 2.1 by an amino group interferes with Mg2+ binding and efficient cleavage by hammerhead ribozyme
Biochem. Biophys. Res. Commun., 262 (2), 461-466
DOI 10.1006/bbrc.1999.1236

Publications 1998

Iversen PO, Sioud M (1998)
Modulation of granulocyte-macrophage colony-stimulating factor gene expression by a tumor necrosis factor specific ribozyme in juvenile myelomonocytic leukemic cells
92 (11), 4263-8
PubMed 9834232

Iversen PO, Sioud M (1998)
Modulation of granulocyte-macrophage colony-stimulating factor gene expression by a tumor necrosis factor alpha specific ribozyme in juvenile myelomonocytic leukemic cells
Blood, 92 (11), 4263-4268
DOI 10.1182/blood.V92.11.4263.422k46_4263_4268

Leirdal M, Sioud M (1998)
High cleavage activity and stability of hammerhead ribozymes with a uniform 2 '-amino pyrimidine modification
Biochem. Biophys. Res. Commun., 250 (1), 171-174
DOI 10.1006/bbrc.1998.9286

Sioud M, Mellbye O, Forre O (1998)
Analysis of the NF-kappa B p65 subunit, Fas antigen, Fas ligand and Bcl-2-related proteins in the synovium of RA and polyarticular JRA
Clin. Exp. Rheumatol., 16 (2), 125-134

Sioud M, Mellbye O, Førre O (1998)
Analysis of the NF-kappa B p65 subunit, Fas antigen, Fas ligand and Bcl-2-related proteins in the synovium of RA and polyarticular JRA
16 (2), 125-34
PubMed 9536387

Sioud M, Sorensen DR (1998)
A nuclease-resistant protein kinase C alpha ribozyme blocks glioma cell growth
Nat. Biotechnol., 16 (6), 556-561
DOI 10.1038/nbt0698-556

Publications 1997

Dybwad A, Forre O, Sioud M (1997)
Probing for cerebrospinal fluid antibody specificities by a panel of random peptide libraries
Autoimmunity, 25 (2), 85-89
DOI 10.3109/08916939708996274

Sioud M (1997)
Effects of variations in length of hammerhead ribozyme antisense arms upon the cleavage of longer RNA substrates
25 (2), 333-8
DOI 10.1093/nar/25.2.333, PubMed 9016562

Sioud M, Opstad A, Hendry P, Lockett TJ, Jennings PA, McCall MJ (1997)
A minimised hammerhead ribozyme with activity against interleukin-2 in human cells
231 (2), 397-402
DOI 10.1006/bbrc.1997.6099, PubMed 9070287

Publications 1996

Dybwad A, Førre O, Sioud M (1996)
Increased serum and synovial fluid antibodies to immunoselected peptides in patients with rheumatoid arthritis
55 (7), 437-41
DOI 10.1136/ard.55.7.437, PubMed 8774161

Fakhfakh F, Ayadi H, Bahloul Z, Jarraya A, Sioud M, Zouali M (1996)
Antibody epitopes probed by immunoselected phage-display library peptides in members of a family with various rheumatic manifestations
Clin. Exp. Rheumatol., 14 (6), 607-611

Sioud M (1996)
Ribozyme modulation of lipopolysaccharide-induced tumor necrosis factor-alpha production by peritoneal cells in vitro and in vivo
26 (5), 1026-31
DOI 10.1002/eji.1830260511, PubMed 8647163

Sioud M, Førre O, Dybwad A (1996)
Selection of ligands for polyclonal antibodies from random peptide libraries: potential identification of (auto)antigens that may trigger B and T cell responses in autoimmune diseases
79 (2), 105-14
DOI 10.1006/clin.1996.0057, PubMed 8620616

Sioud M, Jespersen L (1996)
Enhancement of hammerhead ribozyme catalysis by glyceraldehyde-3-phosphate dehydrogenase
257 (4), 775-89
DOI 10.1006/jmbi.1996.0201, PubMed 8636981

Publications 1995

DYBWAD A, BOGEN B, NATVIG JB, FORRE O, SIOUD M (1995)
PEPTIDE PHAGE LIBRARIES CAN BE AN EFFICIENT TOOL FOR IDENTIFYING ANTIBODY LIGANDS FOR POLYCLONAL ANTISERA
Clin. Exp. Immunol., 102 (2), 438-442

Dybwad A, Bogen B, Natvig JB, Førre O, Sioud M (1995)
Peptide phage libraries can be an efficient tool for identifying antibody ligands for polyclonal antisera
102 (2), 438-42
DOI 10.1111/j.1365-2249.1995.tb03802.x, PubMed 7586703

Dybwad A, Førre O, Natvig JB, Sioud M (1995)
Structural characterization of peptides that bind synovial fluid antibodies from RA patients: a novel strategy for identification of disease-related epitopes using a random peptide library
75 (1), 45-50
DOI 10.1006/clin.1995.1051, PubMed 7533685

Kjeldsen-Kragh J, Mellbye OJ, Haugen M, Mollnes TE, Hammer HB, Sioud M, Førre O (1995)
Changes in laboratory variables in rheumatoid arthritis patients during a trial of fasting and one-year vegetarian diet
24 (2), 85-93
DOI 10.3109/03009749509099290, PubMed 7747149

Kjeldsen-Kragh J, Rashid T, Dybwad A, Sioud M, Haugen M, Førre O, Ebringer A (1995)
Decrease in anti-Proteus mirabilis but not anti-Escherichia coli antibody levels in rheumatoid arthritis patients treated with fasting and a one year vegetarian diet
54 (3), 221-4
DOI 10.1136/ard.54.3.221, PubMed 7748020

OSTENSTAD B, DYBWAD A, LEA T, FORRE O, VINJE O, SIOUD M (1995)
EVIDENCE FOR MONOCLONAL EXPANSION OF SYNOVIAL T-CELLS BEARING V-ALPHA-2.1/V-BETA-5.5 GENE SEGMENTS AND RECOGNIZING A SYNTHETIC PEPTIDE THAT SHARES HOMOLOGY WITH A NUMBER OF PUTATIVE AUTOANTIGENS
Immunology, 86 (2), 168-175

Ostenstad B, Dybwad A, Lea T, Førre O, Vinje O, Sioud M (1995)
Evidence for monoclonal expansion of synovial T cells bearing V alpha 2.1/V beta 5.5 gene segments and recognizing a synthetic peptide that shares homology with a number of putative autoantigens
86 (2), 168-75
PubMed 7490114

Ostenstad B, Sioud M, Schlichting E, Lea T, Harboe M (1995)
Freshly isolated tumour-infiltrating T-lymphocytes have a high cytotoxic potential, as measured by their ability to induce apoptosis in the target cell
41 (1), 42-8
DOI 10.1111/j.1365-3083.1995.tb03531.x, PubMed 7824887

Publications 1994

NATVIG JB, WILSON KB, QUAYLE A, SULEYMAN S, KJELDSENKRAGH J, FORRE O, SIOUD M, CAPRA JD (1994)
T-CELL RECEPTOR VARIABLE GENE REPERTOIRE IN RHEUMATOID SYNOVIAL T-CELLS RESPONDING TO BCG
NATO ADV SCI INST SE, 80, 191-196

Ostenstad B, Sioud M, Lea T, Schlichting E, Harboe M (1994)
Limited heterogeneity in the T-cell receptor V-gene usage in lymphocytes infiltrating human colorectal tumours
69 (6), 1078-82
DOI 10.1038/bjc.1994.211, PubMed 8198973

SIOUD M (1994)
INTERACTION BETWEEN TUMOR-NECROSIS-FACTOR-ALPHA RIBOZYME AND CELLULAR PROTEINS - INVOLVEMENT IN RIBOZYME STABILITY AND ACTIVITY
J. Mol. Biol., 242 (5), 619-629
DOI 10.1006/jmbi.1994.1612

SIOUD M, DYBWAD A, JESPERSEN L, SULEYMAN S, NATVIG JB, FORRE O (1994)
CHARACTERIZATION OF NATURALLY-OCCURRING AUTOANTIBODIES AGAINST TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) - IN-VITRO FUNCTION AND PRECISE EPITOPE MAPPING BY PHAGE EPITOPE LIBRARY
Clin. Exp. Immunol., 98 (3), 520-525

Sioud M, Dybwad A, Jespersen L, Suleyman S, Natvig JB, Førre O (1994)
Characterization of naturally occurring autoantibodies against tumour necrosis factor-alpha (TNF-alpha): in vitro function and precise epitope mapping by phage epitope library
98 (3), 520-5
DOI 10.1111/j.1365-2249.1994.tb05522.x, PubMed 7994916

SIOUD M, OPSTAD A, ZHAO JQ, LEVITZ R, BENHAM C, DRLICA K (1994)
IN-VIVO DECAY KINETIC-PARAMETERS OF HAMMERHEAD RIBOZYMES
Nucleic Acids Res., 22 (25), 5571-5575
DOI 10.1093/nar/22.25.5571

Suleyman S, Thompson KM, Førre O, Sioud M, Randen I, Mageed RA, Natvig JB (1994)
Three new cross-reacting idiotopes as markers for the products of two distinct human VH3 genes expressed in the early repertoire
40 (6), 681-90
DOI 10.1111/j.1365-3083.1994.tb03524.x, PubMed 7527936

Publications 1993

Dybwad A, Førre O, Kjeldsen-Kragh J, Natvig JB, Sioud M (1993)
Identification of new B cell epitopes in the sera of rheumatoid arthritis patients using a random nanopeptide phage library
23 (12), 3189-93
DOI 10.1002/eji.1830231222, PubMed 7504991

FORRE O, SIOUD M (1993)
T-CELL RECEPTOR VARIABLE REGION GENE USAGE IN JUVENILE CHRONIC ARTHRITIS
Clin. Exp. Rheumatol., 11 9, S43-S46

Førre O, Sioud M (1993)
T cell receptor variable region gene usage in juvenile chronic arthritis
11 Suppl 9, S43-6
PubMed 8354007

Kjeldsen-Kragh J, Quayle AJ, Skålhegg BS, Sioud M, Førre O (1993)
Selective activation of resting human gamma delta T lymphocytes by interleukin-2
23 (9), 2092-9
DOI 10.1002/eji.1830230908, PubMed 8370391

SULEYMAN S, HOSONO O, SIOUD M, RANDEN I, THOMPSON KM, FORRE O, NATVIG JB (1993)
DIFFERENTIATION OF HUMAN-LAMBDA-1 VARIABLE REGIONS WITH A MONOCLONAL-ANTIBODY TO A DEFINED, GERM-LINE-ENCODED IDIOTOPE CORRELATES WITH V-LAMBDA-1A CHEMICAL-STRUCTURE
J. Immunol., 150 (12), 5466-5475

Suleyman S, Hosono O, Sioud M, Randen I, Thompson KM, Førre O, Natvig JB (1993)
Differentiation of human lambda I variable regions with a monoclonal antibody to a defined, germ-line-encoded idiotope correlates with V lambda Ia chemical structure
150 (12), 5466-75
PubMed 8515071

Publications 1992

Quayle AJ, Wilson KB, Li SG, Kjeldsen-Kragh J, Oftung F, Shinnick T, Sioud M, Førre O, Capra JD, Natvig JB (1992)
Peptide recognition, T cell receptor usage and HLA restriction elements of human heat-shock protein (hsp) 60 and mycobacterial 65-kDa hsp-reactive T cell clones from rheumatoid synovial fluid
22 (5), 1315-22
DOI 10.1002/eji.1830220529, PubMed 1577070

Sioud M, Kjeldsen-Kragh J, Suleyman S, Vinje O, Natvig JB, Førre O (1992)
Limited heterogeneity of T cell receptor variable region gene usage in juvenile rheumatoid arthritis synovial T cells
22 (9), 2413-8
DOI 10.1002/eji.1830220934, PubMed 1387614

Sioud M, Natvig JB, Førre O (1992)
Preformed ribozyme destroys tumour necrosis factor mRNA in human cells
223 (4), 831-5
DOI 10.1016/0022-2836(92)90244-e, PubMed 1538398

Waalen K, Sioud M, Natvig JB, Førre O (1992)
Spontaneous in vivo gene transcription of interleukin-2, interleukin-3, interleukin-4, interleukin-6, interferon-gamma, interleukin-2 receptor (CD25) and proto-oncogene c-myc by rheumatoid synovial T lymphocytes
36 (6), 865-73
DOI 10.1111/j.1365-3083.1992.tb03148.x, PubMed 1462123

Publications 1991

SIOUD M, DRLICA K (1991)
PREVENTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INTEGRASE EXPRESSION IN ESCHERICHIA-COLI BY A RIBOZYME
Proc. Natl. Acad. Sci. U. S. A., 88 (16), 7303-7307
DOI 10.1073/pnas.88.16.7303

Sioud M, Førre O, Natvig JB (1991)
T cell receptor delta diversity of freshly isolated T lymphocytes in rheumatoid synovitis
21 (1), 239-41
DOI 10.1002/eji.1830210137, PubMed 1825059

Sioud M, Kjeldsen-Kragh J, Quayle AJ, Wiker HG, Sørskaar D, Natvig JB, Førre O (1991)
Immune responses to 18.6 and 30-kDa mycobacterial antigens in rheumatoid patients, and V beta usage by specific synovial T-cell lines and fresh T cells
34 (6), 803-12
DOI 10.1111/j.1365-3083.1991.tb01605.x, PubMed 1836278

Publications 1990

Pascual V, Randen I, Thompson K, Sioud M, Forre O, Natvig J, Capra JD (1990)
The complete nucleotide sequences of the heavy chain variable regions of six monospecific rheumatoid factors derived from Epstein-Barr virus-transformed B cells isolated from the synovial tissue of patients with rheumatoid arthritis. Further evidence that some autoantibodies are unmutated copies of germ line genes
86 (4), 1320-8
DOI 10.1172/JCI114841, PubMed 2170450

Sioud M, Kjeldsen-Kragh J, Quayle A, Kalvenes C, Waalen K, Førre O, Natvig JB (1990)
The V delta gene usage by freshly isolated T lymphocytes from synovial fluids in rheumatoid synovitis: a preliminary report
31 (4), 415-21
DOI 10.1111/j.1365-3083.1990.tb02787.x, PubMed 1692153

Publications 1989

Quayle A, Kjeldsen-Kragh J, Førre O, Waalen K, Sioud M, Kalvenes C, Natvig JB (1989)
Immunoregulatory T cell subsets and T cell activation in rheumatoid arthritis. A need for analysis on the clonal and molecular level
11 (3), 273-87
DOI 10.1007/BF00197307, PubMed 2575800

QUAYLE A, KJELDSENKRAGH J, FORRE O, WAALEN K, SIOUD M, KALVENES C, NATVIG JB (1989)
IMMUNOREGULATORY T-CELL SUBSETS AND T-CELL ACTIVATION IN RHEUMATOID-ARTHRITIS - A NEED FOR ANALYSIS ON THE CLONAL AND MOLECULAR-LEVEL
Springer Semin. Immunopathol., 11 (3), 273-287